Diagnostic and prognostic tests in systemic lupus erythematosus

Diagnostic and prognostic tests in systemic lupus erythematosus

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Natalia Vasquez‐Canizares, Dawn M. Wahezi, Chaim Putterman
Hōputu:	Revisão
Reo:	Ingarihi
I whakaputaina:	2017
Urunga tuihono:	https://doi.org/10.1016/j.berh.2017.10.002
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Diagnostic and Prognostic Tests in Systemic Lupus Erythematosus
mā: Vasquez-Canizares, Natalia, me ētahi atu.
I whakaputaina: (2017)

Systemic Lupus Erythematosus
mā: Putterman, Chaim, me ētahi atu.
I whakaputaina: (2012)

Development of murine systemic lupus erythematosus in the absence of BAFF
mā: Stohl, William, me ētahi atu.
I whakaputaina: (2019)

Hydroxychloroquine Use Is Associated with Lower Odds of Persistently Positive Antiphospholipid Antibodies and/or Lupus Anticoagulant in Systemic Lupus Erythematosus
mā: Anna Broder, me ētahi atu.
I whakaputaina: (2012)

Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus
mā: Erica Moore, me ētahi atu.
I whakaputaina: (2019)

The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
mā: Maria Gulinello, me ētahi atu.
I whakaputaina: (2011)

B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus
mā: Dörner, Thomas, me ētahi atu.
I whakaputaina: (2001)

The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
mā: Gulinello, Maria, me ētahi atu.
I whakaputaina: (2011)

Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus
mā: Moore, Erica, me ētahi atu.
I whakaputaina: (2020)

Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort
mā: Gross, Rachel, me ētahi atu.
I whakaputaina: (2014)

The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus
mā: Moore, Erica, me ētahi atu.
I whakaputaina: (2020)

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice
mā: Ariel Stock, me ētahi atu.
I whakaputaina: (2015)

Metabolic Disturbances Associated with Systemic Lupus Erythematosus
mā: Wu, Tianfu, me ētahi atu.
I whakaputaina: (2012)

Metabolic Disturbances Associated with Systemic Lupus Erythematosus
mā: Tianfu Wu, me ētahi atu.
I whakaputaina: (2012)

Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies
mā: Perron, Megan Mariko, me ētahi atu.
I whakaputaina: (2021)

Phoenix from the flames: Rediscovering the role of the CD40–CD40L pathway in systemic lupus erythematosus and lupus nephritis
mā: Meera Ramanujam, me ētahi atu.
I whakaputaina: (2020)

Dispensability of APRIL to development of systemic lupus erythematosus in NZM 2328 mice
mā: Jacob, Chaim O., me ētahi atu.
I whakaputaina: (2012)

Remodeling of Neurotransmission, Chemokine, and PI3K-AKT Signaling Genomic Fabrics in Neuropsychiatric Systemic Lupus Erythematosus
mā: Iacobas, Dumitru, me ētahi atu.
I whakaputaina: (2021)

Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling
mā: Elise V. Mike, me ētahi atu.
I whakaputaina: (2018)

Fn14 deficiency protects lupus-prone mice from histological lupus erythematosus-like skin inflammation induced by ultraviolet light
mā: Doerner, Jessica, me ētahi atu.
I whakaputaina: (2016)

Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling
mā: Mike, Elise V., me ētahi atu.
I whakaputaina: (2018)

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus
mā: Rosalind Ramsey‐Goldman, me ētahi atu.
I whakaputaina: (2019)

AN EVALUATION OF A NEW DIAGNOSTIC TEST FOR SYSTEMIC LUPUS ERYTHEMATOSUS
mā: Wilkinson, M., me ētahi atu.
I whakaputaina: (1958)

Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights
mā: Julius Lindblom, me ētahi atu.
I whakaputaina: (2022)

3233 Von Willebrand Factor is Localized in the Extravascular tissue of Patients with Juvenile Scleroderma
mā: Canizares, Natalia Vasquez, me ētahi atu.
I whakaputaina: (2019)

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus
mā: Ramsey‐Goldman, Rosalind, me ētahi atu.
I whakaputaina: (2019)

Measurement of cell‐bound complement activation products enhances diagnostic performance in systemic lupus erythematosus
mā: Kenneth Kalunian, me ētahi atu.
I whakaputaina: (2012)

Upregulation of pro-inflammatory bradykinin peptides in systemic lupus erythematosus and rheumatoid arthritis
mā: Vanarsa, Kamala, me ētahi atu.
I whakaputaina: (2020)

B Cell and BAFF Dependence of IFN-α–Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice
mā: Noam Jacob, me ētahi atu.
I whakaputaina: (2011)

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus
mā: Wen, Jing, me ētahi atu.
I whakaputaina: (2016)

Diagnostic issues in systemic lupus erythematosus
I whakaputaina: (2001)

Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor
mā: Jacob, Chaim O., me ētahi atu.
I whakaputaina: (2013)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
mā: Julie Schwartzman-Morris, me ētahi atu.
I whakaputaina: (2012)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
mā: Schwartzman-Morris, Julie, me ētahi atu.
I whakaputaina: (2012)

Prognostic parameters for flare in systemic lupus erythematosus
mā: M. Javad Mirzayan
I whakaputaina: (2000)

The lupus band test in systemic lupus erythematosus patients
mā: Adam Reich, me ētahi atu.
I whakaputaina: (2011)

The lupus band test in systemic lupus erythematosus patients
mā: Reich, Adam, me ētahi atu.
I whakaputaina: (2011)

Systemic lupus erythematosus diagnostics in the ‘omics’ era
mā: Arriens, Cristina, me ētahi atu.
I whakaputaina: (2013)

Laboratory Test in Systemic Lupus Erythematosus
I whakaputaina: (1964)

SLE-key(®) Rule-Out Serologic Test for Excluding the Diagnosis of Systemic Lupus Erythematosus: Developing the ImmunArray iCHIP(®)
mā: Putterman, Chaim, me ētahi atu.
I whakaputaina: (2015)